- Home
- AVR vs POET Comparison
AVR vs POET Comparison
Compare AVR & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVR
- POET
- Stock Information
- Founded
- AVR 1999
- POET 1972
- Country
- AVR Australia
- POET Canada
- Employees
- AVR N/A
- POET N/A
- Industry
- AVR
- POET Semiconductors
- Sector
- AVR
- POET Technology
- Exchange
- AVR NYSE
- POET Nasdaq
- Market Cap
- AVR 241.5M
- POET 275.1M
- IPO Year
- AVR 2024
- POET N/A
- Fundamental
- Price
- AVR $3.27
- POET $3.82
- Analyst Decision
- AVR Strong Buy
- POET Strong Buy
- Analyst Count
- AVR 4
- POET 2
- Target Price
- AVR $16.50
- POET $6.25
- AVG Volume (30 Days)
- AVR 317.0K
- POET 870.3K
- Earning Date
- AVR 05-16-2025
- POET 05-14-2025
- Dividend Yield
- AVR N/A
- POET N/A
- EPS Growth
- AVR N/A
- POET N/A
- EPS
- AVR N/A
- POET N/A
- Revenue
- AVR $2,703,000.00
- POET $41,427.00
- Revenue This Year
- AVR $29.52
- POET $9,379.33
- Revenue Next Year
- AVR $204.83
- POET $684.42
- P/E Ratio
- AVR N/A
- POET N/A
- Revenue Growth
- AVR N/A
- POET N/A
- 52 Week Low
- AVR $2.34
- POET $1.20
- 52 Week High
- AVR $8.79
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- AVR N/A
- POET 48.74
- Support Level
- AVR N/A
- POET $3.58
- Resistance Level
- AVR N/A
- POET $3.83
- Average True Range (ATR)
- AVR 0.00
- POET 0.34
- MACD
- AVR 0.00
- POET 0.03
- Stochastic Oscillator
- AVR 0.00
- POET 66.19
About AVR ANTERIS TECHNOLOGIES GLOBAL CORP
Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The group's operations are located in Allentown, PA, Shenzhen, China, and Singapore.